Eric Schmidt-backed nonprofit FutureHouse is previewing an AI tool for 'data-driven' biology discovery, called Finch.

Anthropic is launching an AI for Science program to support researchers working on 'high-impact' scientific projects.

Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development INDIANAPOLIS and EHIME, Japan, May 5, 2025 /PRNewswire/ -- ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Vector BioMed (VBM), a leading lentiviral vector CDMO advancing access to gene therapies, will showcase its innovations at two major industry events this May: the International Society for Cell & Gene ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

A new study in npj Viruses warns that global trends like urbanization, travel, and mosquito spread are amplifying the risk of ...

I know firsthand how a misaligned gene vector can lead to ineffective therapies, just as misallocated business resources result in inefficiencies and missed opportunities. In both biotech and ...

Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric ...

Analysts are pounding the table on these tech stocks.

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...